NCI Approves New $104M Clinical Proteomics Technologies Initiative

NEW YORK, July 1 (GenomeWeb News) - The National Cancer Institute's Board of Scientific Advisors has approved a five-year, $104 million budget for a new program aimed at optimizing current proteomic technologies.

The program, called the Clinical Proteomics Technologies Initiative, hopes to optimize current proteomic technologies by improving reproducibility, standardization of data formats, throughput capabilities, sample preparation and handling, sensitivity, and specificity.

In addition, the program aims to develop new technologies, reagents, systems, and working consortia to advance the field of cancer proteomics research. Funding for the program will be given out over five years.

According to Gregory Downing, the director of NCI's Office of Technology and Industrial Relations, the NCI will issue requests for applications and request for proposals for the new program in the fall.